Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Industries

    O2O model heralds hospital-to-home medical care

    By Zheng Yiran | China Daily | Updated: 2019-12-16 11:20
    Share
    Share - WeChat
    A visitor gets a checkup at Wuzhen Internet Hospital in Tongxiang, Zhejiang province, in November 2018. [Photo/Xinhua]

    Medical treatment in China will increasingly evolve from the current model of patients seeing doctors exclusively in physical hospitals into a combination of initial offline consultations with online follow-up consultations, or the offline-to-online (O2O) model, providing improved efficiency and convenience, industry experts said.

    Xie Fangmin, CEO of Jianke.com, China's leading business-to-consumer pharmaceutical e-commerce platform, believes that it is well-positioned to support healthcare providers to embrace this online future.

    Jianke's telemedicine software provides each registered doctor with a unique QR code. After an initial offline consultation, patients scan this code using their mobile phone to establish a doctor-patient relationship through Jianke's platform, which facilitates online follow-up consultations and electronic prescriptions and prescription refills.

    During its 2019 Partnership Summit, the Guangdong-based company announced its strategic plan for 2020 and beyond, aiming to develop a smart hospital of the future, and expanding from its original "services plus pharmaceutical products" operating model into a true "Hospital to Home", or H2H enabler.

    "By leveraging technological advancements, common medical services, drug services and chronic disease management can move from hospitals to patients' homes. This will improve the patient experience, enhance the availability and accessibility of medical services and medicines, thereby providing patients with an improved quality of life," said Xie.

    He noted that the H2H model has the potential to break down traditional barriers to healthcare access in China, where medical care is still largely delivered offline at physical hospitals. At the same time, it can also help transform the entire healthcare paradigm from disease treatment to preventive care and comprehensive health management.

    "We believe that our model can be especially beneficial to patients suffering from chronic illnesses, such as liver disease, diabetes, cardiovascular and neurodegenerative diseases," he said.

    According to a report from Beijing-based market consultancy Analysys, in 2019, the online transaction volume of prescription drugs is estimated to grow by 42.1 percent year-on-year, while that of offline hospitals and retailers will only increase by 4.3 percent.

    Meanwhile, data from the National Health Commission showed that in 2017, China's online healthcare market reached 32.5 billion yuan ($4.6 billion), 45.87 percent higher than that of the previous year. Industry experts estimated the market will grow to 90 billion yuan by 2020.

    Cheng Ji, deputy secretary-general of the Life Oasis Foundation of the China Primary Health Care Foundation, said that with the help of internet-based healthcare, prescription drugs that would have originally taken over 10 days from prescription to delivery to a patient's home now take only three days.

    "Once a patient has purchased medicine from physical hospitals or offline retailers, they can obtain prescription refills online afterward," Cheng said.

    Xu Jiawei, China business unit head for Cialis and retail distribution at Eli Lilly and Co, said that e-commerce healthcare has transformed the nature of the digital media.

    "Using the communication power of the internet, information can be conveyed to patients directly. E-commerce links hospitals and pharmacies to form a complete healthcare ecosystem, which includes online consultation, offline referral, electronic prescription and drug delivery," he said.

    In April 2018, the State Council, China's Cabinet, issued new guidelines to promote internet-based healthcare, encouraging medical institutions to leverage internet-based technologies to improve the efficiency of medical services.

    In August 2019, the National People's Congress released an amendment, offering further guidance to expressly permit the sale of prescription drugs online.

    Xie from Jianke noted that the H2H model enables doctors to serve patients with greater precision. "In the future, we believe that the H2H model will continue to develop in coordination with changes to social insurance and pensions, while creating value for all stakeholders."

    By the end of October, 100,415 doctors were registered on Jianke's telemedicine platform, growing 2,500 percent year-on-year. Jianke's H2H business unit also partnered with 114 pharmaceutical enterprises, ranking first in the industry, while facilitating 1.6 million online electronic prescriptions.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    国产亚洲精品无码专区| 亚洲不卡无码av中文字幕| 免费无码国产在线观国内自拍中文字幕 | 无码任你躁久久久久久老妇App | 久久久久久无码Av成人影院 | 亚洲天堂中文字幕在线| 中文字幕亚洲精品无码| 无码精品视频一区二区三区| 最近免费中文字幕大全高清大全1| 国产精品无码专区在线观看| 无码午夜人妻一区二区三区不卡视频 | 在线观看免费无码专区| 暖暖日本中文视频| 亚洲av无码国产精品色在线看不卡| 亚洲爆乳精品无码一区二区三区| 欧美日韩中文字幕在线| 在线欧美中文字幕农村电影| 天码av无码一区二区三区四区| 久久人妻少妇嫩草AV无码专区| 丰满日韩放荡少妇无码视频| 国产精品亚洲w码日韩中文| 中文字幕一精品亚洲无线一区| 无码人妻精品一区二区蜜桃百度| 久久无码人妻一区二区三区午夜| 无码永久免费AV网站| 亚洲精品无码永久中文字幕 | 久久精品aⅴ无码中文字字幕重口| 国产在线无码精品电影网| 日本一区二区三区中文字幕| 91中文字幕yellow字幕网| 亚洲 欧美 国产 日韩 中文字幕| 亚洲中久无码不卡永久在线观看| 五月天无码在线观看| 日韩精品无码免费视频| 亚洲AV永久无码精品一区二区| 少妇中文无码高清| 天天看高清无码一区二区三区| 亚洲精品无码永久在线观看| 中文字幕AV中文字无码亚| 今天免费中文字幕视频| 国产高清中文欧美|